StonvexLoading…
StonvexCore line items from CBSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $185.25M | $548.53M | $363.76M | $167.60M |
Net Income | $141.62M | $425.59M | $284.07M | $131.59M |
EPS (Diluted) | $0.96 | $3.18 | $2.12 | $0.93 |
Total Assets | $35.72B | $32.29B | $32.28B | $32.36B |
Total Liabilities | $31.39B | $28.50B | $28.62B | $28.87B |
Cash & Equivalents | $3.84B | $2.95B | $3.15B | $3.27B |
Free Cash Flow OCF − CapEx | $678.42M | $339.81M | $226.53M | $126.02M |
Shares Outstanding | Not available | Not available | Not available | Not available |